摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-2-Amino-3-((2S,3R,4R,5R,6R)-4,5-diacetoxy-6-acetoxymethyl-3-acetylamino-tetrahydro-pyran-2-yloxy)-propionic acid benzyl ester | 100929-06-4

中文名称
——
中文别名
——
英文名称
(S)-2-Amino-3-((2S,3R,4R,5R,6R)-4,5-diacetoxy-6-acetoxymethyl-3-acetylamino-tetrahydro-pyran-2-yloxy)-propionic acid benzyl ester
英文别名
benzyl (2S)-3-[(2S,3R,4R,5R,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-2-aminopropanoate
(S)-2-Amino-3-((2S,3R,4R,5R,6R)-4,5-diacetoxy-6-acetoxymethyl-3-acetylamino-tetrahydro-pyran-2-yloxy)-propionic acid benzyl ester化学式
CAS
100929-06-4
化学式
C24H32N2O11
mdl
——
分子量
524.525
InChiKey
KZUOHMXBDZRQFC-PDHRJTCOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    687.3±55.0 °C(Predicted)
  • 密度:
    1.31±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.27
  • 重原子数:
    37.0
  • 可旋转键数:
    11.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    178.78
  • 氢给体数:
    2.0
  • 氢受体数:
    12.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (S)-2-Amino-3-((2S,3R,4R,5R,6R)-4,5-diacetoxy-6-acetoxymethyl-3-acetylamino-tetrahydro-pyran-2-yloxy)-propionic acid benzyl ester 生成 N-<2-(4-pyridyl)ethoxycarbonyl>-L-(O-allyl)tyrosyl-L-isoleucine tert-butylester
    参考文献:
    名称:
    KUNZ, HORST;BIRNBACH, STEFAN;WERNIG, PETER, CARBOHYDR. RES., 202,(1990) C. 207-223
    摘要:
    DOI:
  • 作为产物:
    描述:
    3,4,6-tri-O-acetyl-2-azido-2-deoxy-β-D-galactopyranosyl chloride 在 硼酸 、 nickel dichloride 吗啉吡啶calcium sulfate 、 sodium tetrahydroborate 、 3 A molecular sieve 、 silver carbonate 作用下, 反应 9.0h, 生成 (S)-2-Amino-3-((2S,3R,4R,5R,6R)-4,5-diacetoxy-6-acetoxymethyl-3-acetylamino-tetrahydro-pyran-2-yloxy)-propionic acid benzyl ester
    参考文献:
    名称:
    具有TN和T抗原结构的糖肽的合成及其与牛血清白蛋白的偶联。
    摘要:
    合成了具有TN和T抗原结构的糖肽,这些肽代表具有血型M特异性的去唾液酸糖蛋白的N端三肽,已使用芴基甲氧基羰基(Fmoc)和2-吡啶基乙氧基羰基(Pyoc)基团进行氨基保护,并使用苄基酯作为羧基封闭基团来合成糖肽功能。Fmoc和Pyoc基团可以通过在碱敏感的O-糖基丝氨酸和-苏氨酸键稳定的条件下用弱碱吗啉处理而除去。用甲醇肼从碳水化合物部分除去酯基,得到TN和T抗原糖肽,其通过碳二亚胺方法与牛血清白蛋白(BSA)偶联,并且没有任何间隔基。所得的缀合物每个蛋白质分子平均包含大于20个糖肽。
    DOI:
    10.1016/0008-6215(90)84081-5
点击查看最新优质反应信息

文献信息

  • Synthetic and Immunological Studies on Clustered Modes of Mucin-Related Tn and TF O-Linked Antigens:  The Preparation of a Glycopeptide-Based Vaccine for Clinical Trials against Prostate Cancer
    作者:Scott D. Kuduk、Jacob B. Schwarz、Xiao-Tao Chen、Peter W. Glunz、Dalibor Sames、Govindaswami Ragupathi、Philip O. Livingston、Samuel J. Danishefsky
    DOI:10.1021/ja9825128
    日期:1998.12.1
    The syntheses of two tumor-associated carbohydrate antigens, Tn and TF, have been achieved using glycal assembly and cassette methodologies. These synthetic antigens were subsequently clustered (c) and immunoconjugated to a carrier protein (KLH or BSA) or a synthetic lipopeptide (pam) for immunological study. Three Tn conjugates were used to vaccinate groups of mice, and all preparations proved to be immunogenic. The Tn(c) covalently linked to KLH (27-KLH) plus the adjuvant QS-21 was the optimal vaccine, inducing high median IgM and IgG titers against Tn(c) by ELISA. These antibodies were strongly reactive with the Tn(c) positive human colon cancer cell line LS-C but not the Tn(c) negative colon cancer cell Line LS-B by FAGS. The antibodies' reactivities with natural antigens were inhibited with synthetic Tn(c) but not with structurally unrelated compounds. On the basis of these results, vaccines containing 27-KLH and 30-pam plus QS-21 are being tested in patients with prostate cancer.
  • α-Selective glycosylation affords mucin-related GalNAc amino acids and diketopiperazines active on Trypanosoma cruzi
    作者:Maristela B. Martins-Teixeira、Vanessa L. Campo、Monica Biondo、Renata Sesti-Costa、Zumira A. Carneiro、João S. Silva、Ivone Carvalho
    DOI:10.1016/j.bmc.2013.01.027
    日期:2013.4
    This work addresses the synthesis and biological evaluation of glycosyl diketopiperazines (DKPs) cyclo[Asp-(alpha GalNAc)Ser] 3 and cyclo[Asp-(alpha GalNAc)Thr] 4 for the development of novel anti-trypanosomal agents and Trypanosoma cruzi trans-sialidase (TcTS) inhibitors. The target compounds were synthetized by coupling reactions between glycosyl amino acids alpha GalNAc-Ser 7 or alpha GalNAc-Thr 8 and the amino acid (O-tBu)-Asp 17, followed by one-pot deprotection-cyclisation reaction in the presence of 20% piperidine in DMF. The protected glycosyl amino acid intermediates 7 and 8 were, in turn, obtained by a-selective, HgBr2-catalysed glycosylation reactions of Fmoc-Ser/Thr benzyl esters 12/14 with alpha GalN(3)Cl 11, being, subsequently, fully deprotected for comparative biological assays. The DKPs 3 and 4 showed relevant anti-trypanosomal effects (IC50 282-124 mu M), whereas glycosyl amino acids 1 and 2 showed better TcTS inhibition (57-79%) than the corresponding DKPs (13-25%). (C) 2013 Elsevier Ltd. All rights reserved.
  • Kunz, Horst; Birnbach, Stefan, Angewandte Chemie, 1986, vol. 98, # 4, p. 354 - 355
    作者:Kunz, Horst、Birnbach, Stefan
    DOI:——
    日期:——
查看更多